DECIDER: artificial intelligence to improve diagnosis and treatment of ovarian cancer

The Institut Pasteur's Systems Biology Group is a partner in a new international project on applications of artificial intelligence (AI) for the diagnosis and treatment of ovarian cancer. The project, entitled DECIDER, has been granted five-year funding by the European Union.

English

Piecing together past epidemics by studying the human genome

Tuberculosis is one of the most deadly infectious diseases in the world, and it is the most deadly disease in Europe's history. It is generally caused by the Mycobacterium tuberculosis bacterium. Scientists have studied the impact of tuberculosis outbreaks on the human genome over the past 10,000 years.

English

Argobio Studio

The Institut Pasteur is a scientific partner of Argobio Studio, a French start-up studio aiming at creating at least five ambitious therapeutic biotech spinouts over the next five years. Argobio will incubate early-stage, highly innovative therapeutic projects up to company creation and Series A venture funding in selected therapeutic areas.

English

Reconstruire les épidémies passées à travers l’étude du génome humain

La tuberculose fait partie des maladies infectieuses les plus mortelles au monde et a été la plus mortelle dans l’histoire de l’Europe. Elle est généralement causée par la bactérie Mycobacterium tuberculosis. Des chercheurs ont étudié l’impact des épidémies de tuberculose sur le génome humain au cours des 10 000 dernières années.

French

DECIDER : l’intelligence artificielle pour améliorer le diagnostic et le traitement du cancer de l’ovaire

Le groupe Biologie des systèmes de l’Institut Pasteur est partenaire d’un nouveau projet international portant sur des applications de l’intelligence artificielle (IA) pour le traitement et le diagnostic du cancer de l’ovaire. Ce projet, nommé DECIDER, est financé pour cinq ans par l’Union européenne.

French

BIGPICTURE: artificial intelligence for a European database of pathology images

The Institut Pasteur's Biological Image Analysis Unit is taking part in a new project selected by the EU's Innovative Medicines Initiative. The project, BIGPICTURE, aims to speed up the development of artificial intelligence (AI) in medicine, especially in biomedical image analysis.

English

Hearing loss: stepping up research

In recent years, progress in research on hearing mechanisms and the factors responsible for hearing disorders has raised hopes for future preventive and curative therapies. Currently the only solutions for hearing loss are external hearing aids and cochlear implants. The issue is becoming increasingly urgent given the number of people affected by hearing loss, the most common sensory disorder in humans. The Hearing Institute, an Institut Pasteur research center inaugurated a year ago, has the ambition to understand auditory perception and is a great hope for people with hearing loss.

English

SARS-CoV-2, COVID-19 epidemic: the Institut Pasteur's response, scientific research and discoveries in 2020

The Institut Pasteur is one of the world's leading centers for research on infectious diseases. This area is therefore one of the priority research areas of its 2019-2023 strategic plan. On January 27, 2020, a 'coronavirus task force' was set up to respond to the urgency of this health crisis, by studying the virus and the disease it causes - the task force was created at a time when the 11 million inhabitants of Wuhan (China) are 'locked down' -. Here is a report summarizing the events and reviewing the Institut Pasteur's main action.

English

Quantitative biological image analysis and cell motility

Biological image analysis using mathematical methods, artificial intelligence and computer visualization techniques has become an essential tool for biological research and an effective driver for new discoveries. In a publication in Patterns (Cell Press)1, scientists from the "Bioimage Analysis Unit"  recently presented the results of multidisciplinary research using quantitative image analysis to shed light on cell motility.

 

English

BIGPICTURE : l’intelligence artificielle pour une base de données européenne d’images de pathologies

L’unité Analyse d’images biologiques de l’Institut Pasteur participe à un nouveau projet sélectionné par l’Initiative européenne pour les médicaments innovants. Le projet, appelé BIGPICTURE, vise à accélérer le développement de l’intelligence artificielle (IA) en médecine, et notamment dans l’analyse d’images biomédicales.

French

Pages

Subscribe to Institut Pasteur RSS
Back to top